Active Pharmaceutical Ingredients

Name of the Product	Pharmacopeia	Tech Pack	CEP	USDMF	Therapeutic Use
Famotidine	IH/IP/EP/USP	Y	-	-	H2 Blocker
Levetiracetam	IP/USP/Ph-Eur/IH	Y	Y	**	Antiepileptic
Molnupiravir	IH	Y	-	-	Antiviral
Rosuvastatin Calcium Amorphous	IP/USP/Ph-Eur/IH	Y	*	**	Antilipemic

* – Filing by March 2023     ** – Filing by June 2023

Active Pharmaceutical Ingredients – Under Scale up

Name of the Product	Pharmacopeia	CAS No.	Therapeutic Use
Bempedoic Acid	IH	738606-46-7	Lowering LDL Cholesterol
Pirfenidone	IH/Ph.Eur	53179-13-8	Anti-inflammatory
Rivaroxaban	IH/Ph.Eur	366789-02-8	Anti-asthmatic

Active Pharmaceutical Ingredients - Under Development

Name of the Product	CAS No.	Therapeutic Use
Alogliptin	850649-61-5	Antidiabetic
Clopidogrel Bisulfate Form-II	113665-84-2	Anticoagulant
Dapagliflozin	960404-48-2	Antidiabetic
Etoricoxib	202409-33-4	Anti-inflammatory
Pirfenidone	53179-13-8	Anti-inflammatory
Sitagliptin	486460-32-6	Antidiabetic
Tafamidis	594839-88-0	Familial Amyloid Polyneuropathy
Tamsulosin	106133-20-4	Benign Prostatic Hyperplasia
Tofacitinib citrate	540737-29-9	Janus kinase (JAK) inhibitors
Vildagliptin	274901-16-5	Anti-diabetic
Vonoprazan Fumarate	1260141-27-2	Potassium-competitive acid blocker
Zileuton	111406-87-2	Anti-inflammatory

New Products

Chemical Name	CAS No.	Therapeutic Use
Bempedoic Acid	738606-46-7	Lowering LDL Cholesterol
Vonoprazan Fumarate	1260141-27-2	Potassium-competitive acid blocker

Wish List

Chemical Name	CAS No.	Therapeutic Use